John A MacPhee Insider Trading Transactions
Get free email notifications about insider trading for John A MacPhee.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John A MacPhee. John A MacPhee is EVP, Pres - Strativa in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres Strativa Pharma in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Strativa in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres-Strativa Pharma in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, Pres.-Strativa in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and EVP, President, Strativa Pharm in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres Branded Prod Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Exec VP, Pres, Strativa Pharm in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Pres, Branded Products Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Pres. Branded Products Div in PAR PHARMACEUTICAL COMPANIES, INC. ($PRX) and Director in Adamas Pharmaceuticals Inc ($ADMS).
Latest Insider Trading Transactions of John A MacPhee
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | M | 0.67 | 192,000 | 127,680 | 0 | |
Mar 16 2021 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Buy | M | 0.67 | 192,000 | 127,680 | 197,000 | 5 K to 197 K (+3,840.00 %) |
Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 2.70 | 10,000 | 27,000 | 10,000 | |
Jun 05 2020 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Grant | A | 0.00 | 5,000 | 0 | 5,000 | 0 to 5 K |
Jun 06 2019 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 4.80 | 10,000 | 48,000 | 10,000 | |
Jun 07 2018 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 27.98 | 10,000 | 279,800 | 10,000 | |
Jun 02 2017 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 16.27 | 15,000 | 244,050 | 15,000 | |
Aug 08 2016 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 13.68 | 12,600 | 172,368 | 12,600 | |
Jun 07 2016 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 17.03 | 15,000 | 255,450 | 15,000 | |
May 18 2015 | ADMS | Adamas Pharmaceuti ... | MacPhee John A | Director | Option Exercise | A | 17.97 | 21,000 | 377,370 | 21,000 | |
Jan 13 2011 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Payment of Exercise | F | 35.98 | 19,006 | 683,836 | 105,903 | 124.9 K to 105.9 K (-15.22 %) |
Jan 13 2011 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Grant | A | 0.00 | 21,603 | 0 | 124,909 | 103.3 K to 124.9 K (+20.91 %) |
Jan 06 2011 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Payment of Exercise | F | 39.79 | 1,100 | 43,769 | 103,306 | 104.4 K to 103.3 K (-1.05 %) |
Dec 22 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Payment of Exercise | F | 38.26 | 2,347 | 89,796 | 104,406 | 106.8 K to 104.4 K (-2.20 %) |
Nov 19 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Payment of Exercise | F | 37.72 | 13,043 | 491,982 | 105,989 | 119 K to 106 K (-10.96 %) |
Mar 24 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Payment of Exercise | F | 25.09 | 1,732 | 43,456 | 119,032 | 120.8 K to 119 K (-1.43 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.10 | 100 | 2,510 | 120,764 | 120.9 K to 120.8 K (-0.08 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.09 | 100 | 2,509 | 120,864 | 121 K to 120.9 K (-0.08 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.08 | 400 | 10,032 | 120,964 | 121.4 K to 121 K (-0.33 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.07 | 1,205 | 30,209 | 121,364 | 122.6 K to 121.4 K (-0.98 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.06 | 1,935 | 48,491 | 122,569 | 124.5 K to 122.6 K (-1.55 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.05 | 7,582 | 189,929 | 124,504 | 132.1 K to 124.5 K (-5.74 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.04 | 3,171 | 79,402 | 132,086 | 135.3 K to 132.1 K (-2.34 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.04 | 100 | 2,504 | 135,257 | 135.4 K to 135.3 K (-0.07 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.03 | 3,299 | 82,574 | 135,357 | 138.7 K to 135.4 K (-2.38 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.02 | 3,802 | 95,126 | 138,586 | 142.4 K to 138.6 K (-2.67 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.02 | 200 | 5,003 | 142,388 | 142.6 K to 142.4 K (-0.14 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.01 | 2,800 | 70,028 | 142,588 | 145.4 K to 142.6 K (-1.93 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.00 | 3,129 | 78,225 | 145,388 | 148.5 K to 145.4 K (-2.11 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 25.00 | 100 | 2,500 | 148,517 | 148.6 K to 148.5 K (-0.07 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.99 | 3,409 | 85,191 | 148,617 | 152 K to 148.6 K (-2.24 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.98 | 1,578 | 39,418 | 152,026 | 153.6 K to 152 K (-1.03 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.97 | 2,400 | 59,928 | 153,604 | 156 K to 153.6 K (-1.54 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.96 | 900 | 22,464 | 156,004 | 156.9 K to 156 K (-0.57 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.95 | 1,100 | 27,445 | 156,904 | 158 K to 156.9 K (-0.70 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.94 | 200 | 4,988 | 158,004 | 158.2 K to 158 K (-0.13 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.93 | 200 | 4,986 | 158,204 | 158.4 K to 158.2 K (-0.13 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.92 | 200 | 4,984 | 158,404 | 158.6 K to 158.4 K (-0.13 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.91 | 700 | 17,437 | 158,604 | 159.3 K to 158.6 K (-0.44 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.89 | 300 | 7,467 | 159,304 | 159.6 K to 159.3 K (-0.19 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.88 | 200 | 4,976 | 159,604 | 159.8 K to 159.6 K (-0.13 %) |
Mar 10 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Sell | S | 24.87 | 800 | 19,896 | 159,804 | 160.6 K to 159.8 K (-0.50 %) |
Jan 12 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres - Strativ ... | Payment of Exercise | F | 25.80 | 1,017 | 26,239 | 160,380 | 161.4 K to 160.4 K (-0.63 %) |
Jan 12 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres - Strativ ... | Payment of Exercise | F | 25.80 | 1,349 | 34,804 | 161,397 | 162.7 K to 161.4 K (-0.83 %) |
Jan 06 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Option Exercise | A | 27.71 | 23,457 | 649,993 | 23,457 | |
Jan 06 2010 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Grant | A | 0.00 | 11,729 | 0 | 162,746 | 151 K to 162.7 K (+7.77 %) |
Dec 22 2009 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Payment of Exercise | F | 26.04 | 1,807 | 47,054 | 151,017 | 152.8 K to 151 K (-1.18 %) |
Sep 10 2009 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Payment of Exercise | F | 21.19 | 628 | 13,307 | 152,502 | 153.1 K to 152.5 K (-0.41 %) |
Mar 24 2009 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Payment of Exercise | F | 11.19 | 1,732 | 19,381 | 152,057 | 153.8 K to 152.1 K (-1.13 %) |
Jan 14 2009 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Payment of Exercise | F | 12.59 | 1,017 | 12,804 | 153,789 | 154.8 K to 153.8 K (-0.66 %) |
Jan 12 2009 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres.-Strativa | Option Exercise | A | 13.06 | 99,541 | 1,300,005 | 99,541 | |
Jan 12 2009 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres.-Strativa | Payment of Exercise | F | 12.83 | 1,599 | 20,515 | 154,806 | 156.4 K to 154.8 K (-1.02 %) |
Jan 12 2009 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres.-Strativa | Payment of Exercise | F | 13.59 | 496 | 6,741 | 156,405 | 156.9 K to 156.4 K (-0.32 %) |
Dec 23 2008 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa | Payment of Exercise | F | 12.43 | 1,807 | 22,461 | 156,432 | 158.2 K to 156.4 K (-1.14 %) |
Nov 20 2008 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, President, Str ... | Option Exercise | A | 10.99 | 102,881 | 1,130,662 | 102,881 | |
Nov 20 2008 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, President, Str ... | Grant | A | 0.00 | 45,496 | 0 | 158,239 | 112.7 K to 158.2 K (+40.35 %) |
Oct 20 2008 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres Strativa ... | Buy | P | 10.63 | 7,500 | 79,709 | 112,743 | 105.2 K to 112.7 K (+7.13 %) |
Sep 11 2008 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres-Strativa ... | Payment of Exercise | F | 14.22 | 628 | 8,930 | 104,693 | 105.3 K to 104.7 K (-0.60 %) |
Mar 26 2008 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | EVP, Pres Strativa ... | Payment of Exercise | F | 18.37 | 1,732 | 31,817 | 103,802 | 105.5 K to 103.8 K (-1.64 %) |
Jan 15 2008 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | Exec VP, Pres, Stra ... | Grant | A | 0.00 | 36,489 | 0 | 109,361 | 72.9 K to 109.4 K (+50.07 %) |
Oct 05 2007 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | Exec VP, Pres Brand ... | Buy | P | 18.70 | 3,000 | 56,100 | 11,407 | 8.4 K to 11.4 K (+35.68 %) |
Mar 26 2007 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | Exec VP, Pres Brand ... | Option Exercise | A | 24.27 | 10,800 | 262,116 | 10,800 | |
Mar 26 2007 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | Exec VP, Pres Brand ... | Grant | A | 0.00 | 20,700 | 0 | 49,328 | 28.6 K to 49.3 K (+72.31 %) |
Dec 22 2006 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | Pres. Branded Produ ... | Grant | A | 0.00 | 21,600 | 0 | 21,600 | 0 to 21.6 K |
Jan 11 2006 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | Pres, Branded Produ ... | Option Exercise | A | 33.62 | 18,319 | 615,885 | 18,319 | |
Jan 11 2006 | PRX | PAR PHARMACEUTICAL ... | MacPhee John A | Pres, Branded Produ ... | Grant | A | 0.00 | 16,128 | 0 | 23,628 | 7.5 K to 23.6 K (+215.04 %) |
Page: 1